Loading...

PE anti-mouse/human CD11b Antibody

Pricing & Availability
Clone
M1/70 (See other available formats)
Regulatory Status
RUO
Other Names
αM integrin, Mac-1, Mo1, CR3, Ly-40, C3biR, ITGAM
Isotype
Rat IgG2b, κ
Ave. Rating
Submit a Review
Product Citations
publications
M170_PE_042706
C57BL/6 mouse bone marrow cells were stained with CD11b (clone M1/70) PE (filled histogram) or rat IgG2b, κ PE isotype control (open histogram) (gated on total cells).
  • M170_PE_042706
    C57BL/6 mouse bone marrow cells were stained with CD11b (clone M1/70) PE (filled histogram) or rat IgG2b, κ PE isotype control (open histogram) (gated on total cells).
  • M170_PE_CD11b_Antibody_IHC_031413
    Fixed whole mount mouse spleen was stained with Alexa Fluor® 488 F4/80 (red) (clone BM8), Brilliant Violet 421™ CD3ε (green) (clone 145-2C11), and PE CD11b (blue) (clone M1/70). Isotype controls at the same concentrations were used for the negative control. Cells were mounted in Prolong Gold and imaged with a Leica SP8 confocal. Image courtesy of Grzegorz Chodaczek and Zbigniew Mikulski at LIAI.
Compare all formats See PE spectral data See more IHC data...
Cat # Size Price Quantity Check Availability Save
101207 50 µg 45€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
101208 200 µg 139€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD11b is a 170 kD glycoprotein also known as αM integrin, Mac-1 α subunit, Mol, CR3, and Ly-40. CD11b is a member of the integrin family, primarily expressed on granulocytes, monocytes/macrophages, dendritic cells, NK cells, and subsets of T and B cells. CD11b non-covalently associates with CD18 (β2 integrin) to form Mac-1. Mac-1 plays an important role in cell-cell interaction by binding its ligands ICAM-1 (CD54), ICAM-2 (CD102), ICAM-4 (CD242), iC3b, and fibrinogen.

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Mouse, Human, Cynomolgus, Rhesus
Reported Reactivity
Chimpanzee, Baboon, Rabbit
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
C57BL/10 splenocytes
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with PE under optimal conditions.
Concentration
0.2 mg/mL
Storage & Handling
The CD11b antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
IHC - Verified
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 0.25 µg per 106 cells in 100 µL volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Blue Laser (488 nm)
Green Laser (532 nm)/Yellow-Green Laser (561 nm)
Application Notes

Clone M1/70 has been verified for immunocytochemistry (ICC) and frozen immunohistochemistry (IHC-F).

Additional reported applications (for relevant formats of this clone) include: immunoprecipitation1,4, in vitro blocking3,9,12, depletion2,8, immunofluorescence microscopy6,7,10, immunohistochemistry of acetone-fixed frozen sections5,11-13, and spatial biology (IBEX)35,36. For in vivo studies or highly sensitive assays, we recommend Ultra-LEAF™ purified antibody (Endotoxin < 0.01 EU/µg, Azide-Free, 0.2 µm filtered) (Cat. No. 101248).

Additional Product Notes

View more applications data for this product in our Scientific Poster Library.

Application References

(PubMed link indicates BioLegend citation)
  1. Springer T, et al. 1978. Eur. J. Immunol. 8:539. (IP)
  2. Ault K and Springer T. 1981. J. Immunol. 126:359. (Deplete)
  3. Springer TA, et al. 1982. Immunol. Rev. 68:171. (Block)
  4. Ho MK and Springer TA. 1983. J. Biol. Chem. 258:2766. (IP)
  5. Flotte TJ, et al. 1983. Am. J. Pathol. 111:112. (IHC)
  6. Noel GJ, et al. 1990. J. Clin. Invest. 85:208. (IF)
  7. Allen LA and Aderem A. 1996. J. Exp. Med. 184:627 (IF)
  8. D'Amico A and Wu L. 2003. J. Exp. Med. 198:293. (Deplete)
  9. Brickson SJ, et al. 2003. Appl Physiol. 95:969. (Block)
  10. Clatworthy MR and Smith KG. 2004. J. Exp. Med. 199:717. (IF)
  11. Hata H, et al. 2004. J. Clin. Invest. 114:582. (IHC)
  12. Zhang Y, et al. 2002. J. Immunol. 168:3088. (IHC)
  13. Iwasaki A and Kelsall BL. 2001. J. Immunol. 166:4884 (IHC, FC)
  14. Tailleux L. 2003. J. Exp. Med. 197:121. (Block, FC)
  15. Olver S, et al. 2006. Cancer Research 66:571. (FC)
  16. Tan SL, et al. 2006. J. Immunol. 176:2872. (FC) PubMed
  17. Ponomarev ED, et al. 2006. J. Immunol. 176:1402. (FC)
  18. Dzhagalov I, et al. 2007. Blood 109:1620. (FC)
  19. Fazilleau N, et al. 2007. Nature Immunol. 8:753.
  20. Rasmussen JW, et al. 2006. Infect. Immun.74:6590. PubMed
  21. Napimoga MH, et al. 2008. J. Immunol. 180:609. PubMed
  22. Elqaraz-Carmon V, et al. 2008. J. Lipid. Res. 49:1894. PubMed
  23. Kim DD, et al. 2008. Blood 112:1109. PubMed
  24. Guo Y, et al. 2008. Blood 112:480. PubMed
  25. Norian LA, et al. 2009. Cancer Res. 69:3086. (FC) PubMed
  26. Baumgartner CK, et al. 2010. J. Immunol. 184:573. PubMed
  27. Charles N, et al. 2010. Nat. Med. 16:701. (FC) PubMed
  28. Whiteland J, et al. 1995. J. Histochem. Cytochem. 43:313. (IHC)
  29. Weber GF, et al. 2014. J Exp Med. 211:1243. PubMed
  30. Ashok A, et al. 2015. Toxicol Sci. 143:64. PubMed
  31. Price PJ, et al. 2015. J Immunol. 194:1164. PubMed
  32. Doni A, et al. 2015. J Exp Med. 212:905. PubMed
  33. Ferreira R, et al. 2016. J Infect Dis. 213: 669 - 673. PubMed
  34. Peterson VM, et al. 2017. Nat. Biotechnol. 35:936. (PG)
  35. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  36. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Ho YH, et al. 2019. Cell Stem Cell. 25:407. PubMed
  2. Ying W, et al. 2019. Cell Metab. 29:457. PubMed
  3. Yates AG, et al. 2021. J Neuroinflammation. 18:15. PubMed
  4. Witherel CE, et al. 2021. Biomaterials. 269:120667. PubMed
  5. DeBuque RJ, et al. 2022. Dev Dyn. 251:988. PubMed
  6. He D, et al. 2022. Immunity. 55:159. PubMed
  7. Koenig A, et al. 2022. Front Immunol. 12:791100. PubMed
  8. Shang SQ, et al. 2022. Neoplasma. 69:755. PubMed
  9. Tan YY, et al. 2022. Bio Protoc. 12:e4307. PubMed
  10. Wemlinger SM, et al. 2022. J Immunol. 208:1566. PubMed
  11. Li Y, et al. 2022. J Exp Clin Cancer Res. 41:128. PubMed
  12. Martin-Martin I, et al. 2022. Cell Rep. 39:110648. PubMed
  13. Yue Y, et al. 2022. Nat Biomed Eng. 6:898. PubMed
  14. Qin L, et al. 2022. Sci Adv. 8:eabn3774. PubMed
  15. Blanco LP, et al. 2022. Arthritis Rheumatol. 74:1971. PubMed
  16. Albayrak E, et al. 2022. J Cell Biochem. 123:2009. PubMed
  17. Gong F, et al. 2023. Adv Healthc Mater. 12:e2201771. PubMed
  18. Kraemer AN, et al. 2022. Front Immunol. 13:933191. PubMed
  19. McNamara NB, et al. 2023. Nature. 613:120. PubMed
  20. Sundarasivarao PYK, et al. 2022. Front Immunol. 13:1011944. PubMed
  21. Morrow RJ, et al. 2022. Cells. 11: . PubMed
  22. Ullah I, et al. 2023. Cell Rep Med. 4:100893. PubMed
  23. Pavliuchenko N, et al. 2023. Front Immunol. 13:1035226. PubMed
  24. Marritt KL, et al. 2023. Front Immunol. 13:1087991. PubMed
  25. Tanaka T, et al. 2023. Nat Immunol. 24:439. PubMed
  26. Zhao M, et al. 2023. J Nanobiotechnology. 21:50. PubMed
  27. Wang L, et al. 2023. Oxid Med Cell Longev. 2023:6480848. PubMed
  28. Citro A, et al. 2023. Nat Commun. 14:878. PubMed
  29. Kodali S, et al. 2022. J Immunol. 208:1085. PubMed
  30. Tang Y, et al. 2022. Dev Cell. 57:480. PubMed
  31. Marsh SE, et al. 2022. Nat Neurosci. 25:306. PubMed
  32. Ajay AK, et al. 2022. Cell Rep. 38:110473. PubMed
  33. Friedman D, et al. 2022. J Immunol. 208:1845. PubMed
  34. Ramdas B, et al. 2022. Mol Ther. 30:2505. PubMed
  35. Li T, et al. 2022. J Leukoc Biol. 112:845. PubMed
  36. Sauter M, et al. 2022. STAR Protoc. 3:101664. PubMed
  37. Glorieux C, et al. 2022. J Adv Res. 40:109. PubMed
  38. Krasniewski LK, et al. 2022. Elife. 11:. PubMed
  39. Wu Q, et al. 2023. Front Immunol. 13:1081719. PubMed
  40. Suzuki Y, et al. 2023. Front Immunol. 14:1089905. PubMed
  41. Zhang L, et al. 2023. Commun Biol. 6:211. PubMed
  42. Liu N, et al. 2023. Cell Death Dis. 14:170. PubMed
  43. Sang H, et al. 2023. Adv Clin Exp Med. 32:551. PubMed
  44. Ma X, et al. 2023. Nat Commun. 14:1606. PubMed
  45. Mascarau R, et al. 2023. J Cell Biol. 222:. PubMed
  46. Okano F, et al. 2023. Cancer Res Commun. 3:640. PubMed
  47. He Q, et al. 2023. Parasit Vectors. 16:139. PubMed
  48. Petenkova A, et al. 2023. Nat Commun. 14:2761. PubMed
  49. Xu J, et al. 2023. Discov Oncol. 14:68. PubMed
  50. Wang K, et al. 2023. Nat Commun. 14:2950. PubMed
  51. Li M, et al. 2023. BMC Cancer. 23:497. PubMed
  52. Zhao C, et al. 2023. NPJ Regen Med. 8:29. PubMed
  53. Kuo PC, et al. 2021. Brain Commun. 3:fcab187. PubMed
  54. Zhao D, et al. 2021. Innate Immun. 27:533. PubMed
  55. Rosina M, et al. 2022. Cell Metab. 34:533. PubMed
  56. Nigam S, et al. 2020. Mol Imaging Biol. 22:685. PubMed
  57. Hu K, et al. 2022. J Extracell Vesicles. 11:e12199. PubMed
  58. Chida J, et al. 2020. PLoS Pathog. 16:e1008823. PubMed
  59. Guo Y, et al. 2021. Exp Ther Med. 353:21. PubMed
  60. Grigsby SM, et al. 2021. Cancers (Basel). 13:. PubMed
  61. Guo H, Cooper S, Friedman A, et al. 2017. PLoS One. 10.1371/journal.pone.0150809. PubMed
  62. Kisielow J, et al. 2019. Nat Immunol. 1.286111111. PubMed
  63. Li A, et al. 2020. Oncol Lett. 1.899305556. PubMed
  64. Bhatt K, et al. 2018. mSphere. 3:e00352. PubMed
  65. Baryawno N et al. 2019. Cell. 177(7):1915-1932 . PubMed
  66. Abels ER et al. 2019. Cell Rep. 28(12):3105-3119 . PubMed
  67. Paris J et al. 2019. Cell Stem Cell. 25(1):137-148 . PubMed
  68. Prajeeth C,et al. 2017. J Neuroinflammation.. 10.1186/s12974-017-0978-3. PubMed
  69. Schloss MJ, et al. 2022. Nat Immunol. 23:605. PubMed
  70. Yan F, et al. 2022. Cancer Discov. 12:792. PubMed
  71. Lee S, et al. 2021. JCI Insight. 6:. PubMed
  72. Zhao X, et al. 2022. Front Mol Biosci. 9:786864. PubMed
  73. Deng Y, et al. 2021. Acta Pharmacol Sin. 42:149. PubMed
  74. Pan J, et al. 2021. Mol Ther Nucleic Acids. 26:970. PubMed
  75. Lei G, et al. 2016. Antimicrob Agents Chemother. 60: 1289 - 1297. PubMed
  76. Viny AD, et al. 2019. Cell Stem Cell. 25:682. PubMed
  77. Jones NM, et al. 2019. BMC Cancer. 1.127777778. PubMed
  78. Wu N, et al. 2020. Cell Rep. 30:1129. PubMed
  79. Gonçalves NP, et al. 2017. J Neuroinflammation. 14:115. PubMed
  80. Yamauchi T et al. 2018. Cancer cell. 33(3):386-400 . PubMed
  81. Sauter M, et al. 2022. iScience. 25:103677. PubMed
  82. Conforti A, et al. 2021. PLoS One. 16:e0259894. PubMed
  83. Götz P, et al. 2022. Int J Mol Sci. 23:. PubMed
  84. Adachi Y, et al. 2022. Nat Commun. 13:5117. PubMed
  85. Zhang Y, et al. 2020. Oncol Lett. 1.053472222. PubMed
  86. Dumas SJ, et al. 2021. STAR Protocols. 2(3):100523. PubMed
  87. Zhang Z, et al. 2020. J Immunol. 204:3400. PubMed
  88. Li X, et al. 2015. Proc Natl Acad Sci U S A. 112:6080. PubMed
  89. Xiao X, et al. 2020. J Hematol Oncol. 0.597222222. PubMed
  90. Elkabets M, et al. 2009. J Immunol. 182:4874. PubMed
  91. Llewellyn GN, et al. 2018. J Neurovirol. 24:192. PubMed
  92. Sun Y et al. 2018. Cancer cell. 34(4):643-658 . PubMed
  93. Shears RK, et al. 2020. J Allergy Clin Immunol. 145:1272. PubMed
  94. Chen X, et al. 2021. Cell Death Differ. 28:1237. PubMed
  95. Stolp B, et al. 2022. Cell Rep. 38:110387. PubMed
  96. Craver BM, et al. 2020. Blood Adv. 4:312. PubMed
  97. Forte E, et al. 2020. J Cell Mol Med. . PubMed
  98. Earnest JT, et al. 2021. Cell Reports. 35(1):108962. PubMed
  99. Jard T, et al. 2020. Cell Stem Cell. 27(4):646-662.e7. PubMed
  100. Forte D, et al. 2020. Cell Metab. 32:829. PubMed
  101. Coppo M, et al. 2016. Nat Commun. 7:12254. PubMed
  102. Wang X, et al. 2016. PLoS Pathog. 12: 1005367. PubMed
  103. Hiraishi Y, et al. 2018. Sci Rep. 8:18052. PubMed
  104. Wu R, et al. 2019. J Cell Mol Med. 24:1684. PubMed
  105. Turkowski K, et al. 2017. Glia. 10.1002/glia.23234. PubMed
  106. Wiese A, et al. 2017. PLoS One. 10.1371/journal.pone.0184956. PubMed
  107. Hengyou Weng et al. 2018. Cell stem cell. 22(2):191-205 . PubMed
  108. Nakagawa S et al. 2017. Cell host & microbe. 22(5):667-677 . PubMed
  109. Swidergall M, et al. 2019. Cell Rep. 28:423. PubMed
  110. Ganeshan K et al. 2019. Cell. 177(2):399-413 . PubMed
  111. Wang Y, et al. 2022. Acta Pharm Sin B. 12:262. PubMed
  112. Zhou HF, et al. 2022. Front Pharmacol. 13:778755. PubMed
  113. Chen F, et al. 2022. Evid Based Complement Alternat Med. 2022:1240242. PubMed
  114. Xu F, et al. 2022. Cell Death Discov. 8:142. PubMed
  115. Kalucka J, et al. 2020. Cell. 764:180. PubMed
  116. Joseph R, et al. 2021. Br J Cancer. 125:176. PubMed
  117. Park JA, et al. 2021. J Hematol Oncol. 14:142. PubMed
  118. Price J, et al. 2015. Diabetes. 64: 3521 - 3531. PubMed
  119. LaFleur MW, et al. 2019. Nat Immunol. 20:1335. PubMed
  120. Tsuchiya N, et al. 2020. Cell Reports. 29(1):162-175.e9.. PubMed
  121. Fukushima T, et al. 2019. Cell Rep. 29:4144. PubMed
  122. Paraiso HC, et al. 2018. J Neuroinflammation. 0.694444444. PubMed
  123. Pan W et al. 2017. Immunity. 47(2):284-297 . PubMed
  124. Dey A et al. 2019. The EMBO journal. 38(7) pii: e100293. PubMed
  125. Hammond TR, et al. 2019. Immunity. 50:253. PubMed
  126. Wang C, et al. 2017. J Immunol. 10.4049/jimmunol.1700671. PubMed
  127. Li K, et al. 2022. J Immunother Cancer. 10:. PubMed
  128. Hongu T, et al. 2022. Nat Cancer. 3:486. PubMed
  129. Rogawski DS, et al. 2021. Nat Commun. 12:2792. PubMed
  130. Trenevska I, et al. 2021. PLoS One. 16:e0249967. PubMed
  131. Gordon RA, et al. 2020. PLoS One. 15:e0226396. PubMed
  132. Zhang Z, et al. 2021. Oncoimmunology. 10:1912472. PubMed
  133. Haugh KA, et al. 2021. eLife. 0.416666666666667. PubMed
  134. Perner C, et al. 2020. Immunity. 53(5):1063-1077.e7. PubMed
  135. Endo Y, et al. 2020. FASEB J. 34:16086. PubMed
  136. Diao N, et al. 2016. Sci Rep. 6:34672. PubMed
  137. Huang L, et al. 2016. J Biol Chem. 291: 6232 - 6244. PubMed
  138. Sharma S, et al. 2015. J Immunol. 194:5529. PubMed
  139. Pan J, et al. 2020. J Neuroinflammation. 17:97. PubMed
  140. An J,et al. 2017. Sci Rep.. 10.1038/s41598-017-13629-0. PubMed
  141. Wang L, et al. 2017. Front Immunol.. 10.3389/fimmu.2017.01754. PubMed
  142. Kunimoto H, et al. 2018. Cancer Cell. 33:44. PubMed
  143. Parada-Kusz M, et al. 2018. Dis Model Mech. 11:. PubMed
  144. Zhang S, et al. 2019. Mol Med Rep. 19:5377. PubMed
  145. Shimokawa C et al. 2017. Immunity. 46(5):863-874 . PubMed
  146. Riffelmacher T et al. 2017. Immunity. 47(3):466-480 . PubMed
  147. Zheng Y, et al. 2022. Front Pharmacol. 12:816032. PubMed
  148. Dane EL, et al. 2022. Nat Mater. 21:710. PubMed
  149. Guo W, et al. 2022. J Immunother Cancer. 10:. PubMed
  150. Zhang X, et al. 2022. Cells. 11:. PubMed
  151. Donley DW, et al. 2021. PLOS ONE. 16(5):e0250606. PubMed
  152. Jassinskaja M, et al. 2021. Cell Reports. 34(12):108894. PubMed
  153. Ratitong B, et al. 2021. Cell Reports. 35(7):109139. PubMed
  154. Cheng K, et al. 2021. Nat Commun. 12:2041. PubMed
  155. Xiao Z, et al. 2015. Cancer Lett. 360:302. PubMed
  156. Nakaya M, et al. 2017. J Clin Invest. 127:383. PubMed
  157. Mayo L, et al. 2008. J Immunol. 181:92. PubMed
  158. Frazier T, et al. 2018. Adipocyte. 0.41875. PubMed
  159. Deng Z, et al. 2017. Oncogene. 36:639. PubMed
  160. Liu D et al. 2019. Immunity. 51(1):64-76 . PubMed
  161. Anstine L,et al. 2017. J Am Heart Assoc.. 10.1161/JAHA.117.007097. PubMed
  162. Kotaki R, et al. 2020. Sci Rep. 10:13554. PubMed
  163. Wu L, et al. 2022. Theranostics. 12:842. PubMed
  164. Ajina R, et al. 2021. Cancer Immunol Res. 9:386. PubMed
  165. Jin R, et al. 2020. Mol Cancer Ther. . PubMed
  166. Nguyen TKT, et al. 2020. Am J Pathol. 286:190. PubMed
  167. Gereke M, et al. 2012. J Vis Exp. 70: 4322. PubMed
  168. Pang D, et al. 2015. Clin Transl Immunology. 4: e41. PubMed
  169. Bertino P, et al. 2019. Oncoimmunology. 8:1601482. PubMed
  170. Keshavarz M, et al. 2020. Virol J. 17:64. PubMed
  171. He L, et al. 2019. iScience. 0.790972222. PubMed
  172. Hönes J, et al. 2017. Sci Rep. . 10.1038/s41598-017-15866-9. PubMed
  173. Niemann J, et al. 2019. Nat Commun. 10:3236. PubMed
  174. Du Y, et al. 2022. Nat Commun. 13:231. PubMed
  175. Malekghasemi S, et al. 2020. Cell Biol Int. 44:2031. PubMed
  176. Souza COS, et al. 2021. iScience. 24(6):102548. PubMed
  177. Mao FY, et al. 2021. Cell Mol Gastroenterol Hepatol. 12:395. PubMed
  178. Hildebrand KM, et al. 2021. PLoS One. 16:e0253864. PubMed
  179. Jaworska K, et al. 2015. J Immunol. 194:325. PubMed
  180. Chen Y, et al. 2015. PLoS One. 10: 0135217. PubMed
  181. Li L, et al. 2015. J Am Soc Nephrol. 26: 2183-2197. PubMed
  182. Hou M, et al. 2020. Stem Cell Res Ther. 11:55. PubMed
  183. Luong-Gardiol N, et al. 2019. Cancer Cell. 35:649. PubMed
  184. Murray C, et al. 2018. Lab Chip. 18:2396. PubMed
  185. Zhao X, et al. 2022. Nat Protoc. 17:2240. PubMed
  186. Baik JE, et al. 2022. Clin Transl Med. 12:e758. PubMed
  187. Di Martino L, et al. 2021. Cell Mol Gastroenterol Hepatol. 13:901. PubMed
  188. Zhang C, et al. 2022. Nat Commun. 13:3468. PubMed
  189. Lin S, et al. 2022. Nat Commun. 13:3301. PubMed
  190. Ye P, et al. 2022. Front Cardiovasc Med. 8:810477. PubMed
  191. Han D, et al. 2021. J Immunol Res. 6688053:2021. PubMed
  192. Nguyen GT, et al. 2021. iScience. 24(8):102871. PubMed
  193. Garg M, et al. 2021. Cell Reports. 34(6):108736. PubMed
  194. Cao DY, et al. 2020. J Biol Chem. 295:1369. PubMed
  195. Moorlag SJCFM, et al. 2020. Cell Rep. 33:108387. PubMed
  196. Koshida R, et al. 2015. Biochem Biophys Res Commun. 463: 109-115. PubMed
  197. Textor A, et al. 2014. Cancer Res. 74:6769. PubMed
  198. Frodermann V, et al. 2019. Nat Med. 25:1761. PubMed
  199. Xiang W, et al. 2018. Nat Commun. 9:2574. PubMed
  200. LaFleur MW, et al. 2019. Nat Commun. 10:1668. PubMed
  201. He J, et al. 2019. J Clin Invest. 130. PubMed
  202. Huang Y, et al. 2019. Cancer Cell. 35:677. PubMed
  203. Ruiz de Azua I, et al. 2017. J Clin Invest. 127:4148. PubMed
  204. Colombo M, et al. 2022. iScience. 25:105042. PubMed
  205. Jorapur A, et al. 2022. PLoS Pathog. 18:e1010200. PubMed
  206. Yang Y, et al. 2022. Elife. 11:. PubMed
  207. Bolkhovitina EL, et al. 2022. Int J Mol Sci. 23: . PubMed
  208. Mizuno T, et al. 2017. Sci Rep. 7:42714. PubMed
  209. Holokai L, et al. 2020. Cancers (Basel). 12:00. PubMed
  210. Haas MS, et al. 2020. Mol Cancer Res. 19:717. PubMed
  211. Kan X, et al. 2015. Cardiovasc Res. 10.1093/cvr/cvv255. PubMed
  212. Zhang H, et al. 2019. Mol Cell. 76:110. PubMed
  213. Liang J, et al. 2020. Sci Adv. 6:eabc3646. PubMed
  214. Minuesa G, et al. 2019. Nat Commun. 10:2691. PubMed
  215. Zhou J, et al. 2019. Nat Commun. 10:2427. PubMed
  216. Kubota S, et al. 2019. Nat Commun. 10:1653. PubMed
  217. Wang Q, et al. 2018. Int J Biol Sci. 14:147. PubMed
  218. Perez-Garcia CG, et al. 2022. Mol Ther Nucleic Acids. 28:87. PubMed
  219. Uslu M, et al. 2020. J Cell Physiol. 235:9644. PubMed
  220. Zhai K, et al. 2021. Nat Cancer. 2:1136. PubMed
  221. Chiang HY, et al. 2022. Nat Commun. 13:874. PubMed
  222. Rashid MH, et al. 2021. Oncol Rep. 45:1171. PubMed
  223. Bermejo-Jambrina M, et al. 2021. EMBO J. 40:e106765. PubMed
  224. Henrich IC, et al. 2021. Cancer Res. 81:2171. PubMed
  225. Koikawa K, et al. 2021. Cell. 184:4753. PubMed
  226. Sokol L, et al. 2021. STAR Protocols. 2(2):100489. PubMed
  227. Yamakawa D, et al. 2021. Cell Reports. 34(10):108817. PubMed
  228. Troutman TD, et al. 2021. STAR Protocols. 2(1):100363. PubMed
  229. Wang L, et al. 2012. PLoS One. 7:e40056. PubMed
  230. Staschke K, et al. 2009. J Immunol. 183:568. PubMed
  231. Challa TD, et al. 2020. Cell Reports. 30(10):3424-3433. PubMed
  232. Hsu Y, et al. 2017. Biochem Biophys Res Commun.. 10.1016/j.bbrc.2017.10.067. PubMed
  233. Subramanian K, et al. 2019. Nat Microbiol. 4:62. PubMed
  234. Yang BH, et al. 2020. Cell Reports. 27(12):3629-3645.e6.. PubMed
  235. Gomez–Ospina N, et al. 2019. Nat Commun. 3.225694444. PubMed
  236. Roy AG, et al. 2021. Int J Mol Sci. 22:. PubMed
  237. Liu S, et al. 2022. J Neuroinflammation. 19:35. PubMed
  238. Xiao Y, et al. 2022. Nat Commun. 13:758. PubMed
  239. Ali S, et al. 2021. PLoS One. 16:e0246646. PubMed
  240. Nuro-Gyina PK, et al. 2021. J Immunol. 207:868. PubMed
  241. Babagana M, et al. 2021. Aging (Albany NY). 13:19207. PubMed
  242. Li Q, et al. 2022. Front Cardiovasc Med. 9:872102. PubMed
  243. Dungan CM, et al. 2022. Aging Cell. 21:e13528. PubMed
  244. Favuzzi E, et al. 2021. Cell. 184(15):4048-4063.e32. PubMed
  245. Langhauser F, et al. 2014. Stroke. 45:1799. PubMed
  246. Garcia-Bonilla L, et al. 2014. J Immunol. 193:2531. PubMed
  247. Tao Z, et al. 2019. Clin Cancer Res. 25:1113. PubMed
  248. Tan S, et al. 2006. J Immunol. 176:2872. PubMed
  249. Yuan X, et al. 2017. Elife. 6:e29540. PubMed
  250. Li YT, et al. 2019. Elife. 8:e47642. PubMed
  251. Luck H, et al. 2019. Nat Commun. 10:3650. PubMed
  252. Xiao G, et al. 2018. Cell. 173:470. PubMed
  253. Spangenberg E, et al. 2019. Nat Commun. 10:3758. PubMed
  254. Wu ZJ, et al. 2018. Int J Oncol. 52:1209. PubMed
  255. Szeifert V, et al. 2021. Front Immunol. 12:671995. PubMed
  256. Saber M, et al. 2021. J Neurosci Res. 99:1136. PubMed
  257. Wang W, et al. 2021. J Am Heart Assoc. 10:e019142. PubMed
  258. Berghoff SA, et al. 2021. Nat Neurosci. 24:47. PubMed
  259. Cao W, et al. 2021. Int J Mol Sci. 22:. PubMed
  260. Calle P, et al. 2021. Cells. 10:. PubMed
  261. Li T, et al. 2021. J Neuroinflammation. 81:18. PubMed
  262. Guo M, et al. 2020. Brain. 1476:143. PubMed
  263. Houben T, et al. 2020. J Pathol. 251:429. PubMed
  264. Cai Z, et al. 2020. Cell Rep. 31:107816. PubMed
  265. Li L, et al. 2014. J Immunol. 192:1034. PubMed
  266. Demers M, et al. 2012. Proc Natl Acad Sci U S A. 109:13076. PubMed
  267. Gladow N, et al. 2020. PLoS One. 15:e0227734. PubMed
  268. Bennett FC, et al. 2018. Neuron. 98:1170. PubMed
  269. Zhang T, et al. 2018. PLoS One. 13:e0196571. PubMed
  270. Eisemann T, et al. 2019. Front Oncol. 9:187. PubMed
  271. Tomimatsu M, et al. 2022. Sci Rep. 12:16656. PubMed
  272. Yuan Y, et al. 2020. Front Physiol. 0.967361111. PubMed
  273. Varikuti S, et al. 2020. Br J Cancer. 122:1005. PubMed
  274. Toyohara T, et al. 2020. Cell Stem Cell. 27:147. PubMed
  275. Dong Y, et al. 2021. Commun Biol. 4:560. PubMed
  276. Scheiblich H, et al. 2021. Cell. 184:5089. PubMed
  277. Ding H, et al. 2016. Nat Commun. 7:11533. PubMed
  278. Cá B, et al. 2019. Front Microbiol. 1.876388889. PubMed
  279. Clemente–Casares X, et al. 2017. Immunity. 47:974. PubMed
  280. Gerdes P, et al. 2022. Nat Commun. 13:7470. PubMed
  281. Düking T, et al. 2022. Sci Adv. 8:eabo7639. PubMed
  282. Wang X, et al. 2021. Cell. 184:5357. PubMed
  283. Li Y, et al. 2020. Theranostics. 10:2897. PubMed
  284. Xia D, et al. 2022. Mol Neurodegener. 17:41. PubMed
  285. Koide S, et al. 2022. iScience. 25:103603. PubMed
  286. Lin T, et al. 2021. PLoS Pathog. 17:e1009557. PubMed
  287. Casselli T, et al. 2021. PLoS Pathog. 17:e1009256. PubMed
  288. Yokomizo-Nakano T, et al. 2020. Cancer Res. 80:2523. PubMed
  289. Lin KH, et al. 2020. Nat Genet. 52:408. PubMed
  290. Jablonski K, et al. 2015. PLoS One. 10: 0145342. PubMed
  291. Sanders K, et al. 2015. Cancer Immunol Res. 3: 891-901. PubMed
  292. Yuan C, et al. 2015. Biochem Biophys Res Commun. 464: 249-255. PubMed
  293. Resende M, et al. 2013. J Immunol. 191:262. PubMed
  294. Muri J, et al. 2020. Cell Reports. 29(9):2731-2744.e4.. PubMed
  295. Liu Y, et al. 2019. Sci Rep. 9:18970. PubMed
  296. Wang Z et al. 2019. Cell reports. 26(5):1273-1285 . PubMed
  297. Yang N, et al. 2022. Nat Commun. 13:2336. PubMed
  298. Zhai T, et al. 2020. Clin Exp Pharmacol Physiol. 47:677. PubMed
  299. Li K, et al. 2020. Nat Commun. 4.844444444. PubMed
  300. Avalle L, et al. 2020. Mol Ther Methods Clin Dev. 0.793055556. PubMed
  301. Zhou Q, et al. 2020. Nat Immunol. 1.393055556. PubMed
  302. Rodríguez L, et al. 2021. Biomolecules. 11: . PubMed
  303. Chen L, et al. 2021. Theranostics. 11:6668. PubMed
  304. Zhang A, et al. 2021. Theranostics. 11:3839. PubMed
  305. Kuo P, et al. 2016. J Am Heart Assoc. 5: 002610. PubMed
  306. Schaftenaar FH, et al. 2019. Sci Rep. 9:17391. PubMed
  307. Chao Y, et al. 2020. Sci Adv. 6:eaaz4204. PubMed
  308. Nguyen GT, et al. 2020. eLife. 9:e56656.. PubMed
  309. Hoyer FF, et al. 2020. Immunity. 51(5):899-914.e7.. PubMed
  310. Danne C et al. 2017. Cell host & microbe. 22(6):733-745 . PubMed
  311. Luo H, et al. 2019. Cell Rep. 26:945. PubMed
  312. Bozoglu T, et al. 2022. Adv Sci (Weinh). 9:e2103867. PubMed
  313. Shen H, et al. 2022. Nat Commun. 13:5013. PubMed
  314. Zhang X, et al. 2022. J Exp Clin Cancer Res. 41:246. PubMed
  315. Zhou Y, et al. 2022. Theranostics. 12:5488. PubMed
  316. Sheng D, et al. 2022. J Immunother Cancer. 10:. PubMed
  317. Bahmani B, et al. 2021. Nat Commun. 12:1999. PubMed
  318. Fielding C, et al. 2022. Nat Commun. 13:543. PubMed
  319. Saber M, et al. 2020. Eur J Neurosci. 52:2791. PubMed
  320. Garcia-Bonilla L, et al. 2015. J Neurosci. 35: 14783 - 14793. PubMed
  321. Baruch K, et al. 2015. EMBO J. 34: 1816 - 1828. PubMed
  322. Schmidt C, et al. 2005. J Immunol. 175:2286. PubMed
  323. Wunderlich CM, et al. 2018. Nat Commun. 9:1646. PubMed
  324. Arima Y et al. 2017. eLife. 6 pii: e25517. PubMed
  325. Wang T, et al. 2022. Int J Nanomedicine. 17:2191. PubMed
  326. Gawish R, et al. 2022. Elife. 11:. PubMed
  327. Heyde A, et al. 2021. Cell. 184(5):1348-1361.e22. PubMed
  328. Evavold CL, et al. 2021. Cell. 184(17):4495-4511.e19. PubMed
  329. Wu L, et al. 2020. Cancer Immunol Res. 710:8. PubMed
  330. Wang K, et al. 2021. Nat Commun. 12:4558. PubMed
  331. Henkle TR, et al. 2021. Cancer Res. 81:4560. PubMed
  332. Hirako N, et al. 2014. PLoS One. 9:103282. PubMed
  333. Chen Z, et al. 2016. Innate Immunity. 22: 419 - 432. PubMed
  334. Hong Y, et al. 2019. J Extracell Vesicles. 8:1670893. PubMed
  335. Zhang M, et al. 2019. Autophagy. 1.423611111. PubMed
  336. Dougan M, et al. 2018. Cancer Immunol Res. 6:389. PubMed
  337. Abdel Malik R, et al. 2017. Circ Res. 120:99. PubMed
  338. Saber M, et al. 2021. J Neurotrauma. 38:2862. PubMed
  339. Sethuraman SN, et al. 2020. Theranostics. 10:3397. PubMed
  340. Zhang SJ, et al. 2021. Adv Sci (Weinh). 8:2003410. PubMed
  341. Steinmetz TD, et al. 2021. Autophagy. 17:2238. PubMed
  342. Hohsfield LA, et al. 2021. Elife. 10:. PubMed
  343. Kaya-Tilki E, et al. 2021. PLoS One. 16:e0260633. PubMed
  344. Zhang J, et al. 2021. Stem Cell Res Ther. 12:579. PubMed
  345. Amend A, et al. 2021. Int J Mol Sci. 22:. PubMed
  346. Rana MN, et al. 2021. Front Pharmacol. 12:643215. PubMed
  347. Nabekura T, et al. 2020. Immunity. 96:52. PubMed
  348. Wong PP, et al. 2020. Cell. 181(6):1346-1363.e21. PubMed
  349. Guo S, et al. 2021. Frontiers in Immunology. 11:614667. PubMed
  350. Scharenberg SG, et al. 2020. Nat Commun. 2.76875. PubMed
  351. K K, et al. 2016. Haematologica. 151159. PubMed
  352. Han J, et al. 2015. Cancer Res . 75: 5273 - 5282. PubMed
  353. Cai W, et al. 2019. J Neuroinflammation. 0.788194444. PubMed
  354. Fernando N, et al. 2020. Front Cell Dev Biol. 0.691666667. PubMed
RRID
AB_312790 (BioLegend Cat. No. 101207)
AB_312791 (BioLegend Cat. No. 101208)

Antigen Details

Structure
Integrin family, associates with integrin β2 (CD18), 170 kD
Distribution

Granulocytes, monocytes/macrophages, dendritic cells, NK cells, subsets of T and B cells

Function
Adhesion, chemotaxis
Ligand/Receptor
ICAM-1 (CD54), ICAM-2 (CD102), ICAM-4 (CD242), iC3b, fibrinogen
Cell Type
B cells, Dendritic cells, Granulocytes, Macrophages, Monocytes, Neutrophils, NK cells, T cells, Tregs
Biology Area
Cell Adhesion, Cell Biology, Costimulatory Molecules, Immunology, Innate Immunity, Neuroscience, Neuroscience Cell Markers
Molecular Family
Adhesion Molecules, CD Molecules
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Springer TA. 1994. Cell 76:301.
3. Coxon A, et al. 1996. Immunity 5:653.

Gene ID
16409 View all products for this Gene ID 3684 View all products for this Gene ID
Specificity (DOES NOT SHOW ON TDS):
CD11b
Specificity Alt (DOES NOT SHOW ON TDS):
CD11b
App Abbreviation (DOES NOT SHOW ON TDS):
FC,IHC
Hidden Names (DOES NOT SHOW ON TDS):
aM integrin, alpha integrin, alphaM integrin, alpha M integrin, integrin alphaM, integrin aM, integrin alpha M, CD11, Macrophage, Myeloid Dendritic Cell, Neutrophil, NK Cell, Plasmacytoid Dendritic Cell, Microglia
UniProt
View information about CD11b on UniProt.org

Related FAQs

What type of PE do you use in your conjugates?
We use R-PE in our conjugates.

Other Formats

View All CD11b Reagents Request Custom Conjugation
Description Clone Applications
APC anti-mouse/human CD11b M1/70 FC
Biotin anti-mouse/human CD11b M1/70 FC
FITC anti-mouse/human CD11b M1/70 FC
PE anti-mouse/human CD11b M1/70 FC,IHC
PE/Cyanine5 anti-mouse/human CD11b M1/70 FC
Purified anti-mouse/human CD11b M1/70 FC,CyTOF®,IP,IHC-F,ICC
PE/Cyanine7 anti-mouse/human CD11b M1/70 FC
Alexa Fluor® 488 anti-mouse/human CD11b M1/70 FC,IHC-F,3D IHC,SB
Alexa Fluor® 647 anti-mouse/human CD11b M1/70 FC,3D IHC,SB
Alexa Fluor® 700 anti-mouse/human CD11b M1/70 FC
Pacific Blue™ anti-mouse/human CD11b M1/70 FC
APC/Cyanine7 anti-mouse/human CD11b M1/70 FC
PerCP/Cyanine5.5 anti-mouse/human CD11b M1/70 FC
PerCP anti-mouse/human CD11b M1/70 FC
Brilliant Violet 421™ anti-mouse/human CD11b M1/70 FC
Brilliant Violet 570™ anti-mouse/human CD11b M1/70 FC
Brilliant Violet 605™ anti-mouse/human CD11b M1/70 FC
Brilliant Violet 650™ anti-mouse/human CD11b M1/70 FC
Brilliant Violet 711™ anti-mouse/human CD11b M1/70 FC
Brilliant Violet 785™ anti-mouse/human CD11b M1/70 FC
Brilliant Violet 510™ anti-mouse/human CD11b M1/70 FC,ICC
Ultra-LEAF™ Purified anti-mouse/human CD11b M1/70 FC,CyTOF®,IP,Block,Depletion,IHC-F,ICC
Purified anti-mouse/human CD11b (Maxpar® Ready) M1/70 FC,CyTOF®
Alexa Fluor® 594 anti-mouse/human CD11b M1/70 IHC-F,FC
PE/Dazzle™ 594 anti-mouse/human CD11b M1/70 FC
APC/Fire™ 750 anti-mouse/human CD11b M1/70 FC
TotalSeq™-A0014 anti-mouse/human CD11b M1/70 PG
Brilliant Violet 750™ anti-mouse/human CD11b M1/70 FC
TotalSeq™-B0014 anti-mouse/human CD11b M1/70 PG
TotalSeq™-C0014 anti-mouse/human CD11b M1/70 PG
Spark NIR™ 685 anti-mouse/human CD11b M1/70 FC
PE/Fire™ 640 anti-mouse/human CD11b M1/70 FC
Spark YG™ 593 anti-mouse/human CD11b M1/70 FC
Spark YG™ 570 anti-mouse/human CD11b M1/70 IHC-F
PE/Fire™ 810 anti-mouse/human CD11b M1/70 FC
APC/Fire™ 810 anti-mouse/human CD11b Antibody M1/70 FC
Spark Blue™ 550 anti-mouse/human CD11b M1/70 FC
Spark UV™ 387 anti-mouse/human CD11b M1/70 FC
PerCP/Fire™ 806 anti-mouse/human CD11b M1/70 FC
PerCP/Fire™ 780 anti-mouse/human CD11b M1/70 FC
Spark Blue™ 574 anti-mouse/human CD11b (Flexi-Fluor™) M1/70 FC
KIRAVIA Blue 520™ anti-mouse/human CD11b M1/70 FC
PE/Fire™ 744 anti-mouse/human CD11b M1/70 FC
Spark PLUS UV395™ anti-mouse/human CD11b M1/70 FC
Spark Red™ 718 anti-mouse/human CD11b (Flexi-Fluor™) M1/70 FC
Spark PLUS B550™ anti-mouse/human CD11b M1/70 FC
Go To Top Version: 2    Revision Date: 03/14/2013

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account